C. Alverbratt, F. Sandin, V. Kolmbäck, H. Garmo, O. Bratt, and I. Franck Lissbrant, “Radium-223 use and survival by line of treatment in metastatic castration-resistant prostate cancer: a nationwide population-based register study”, AO, vol. 64, pp. 1391–1403, Oct. 2025.